surmount-1 tirzepatide weight loss non-diabetic SURMOUNT-1: Adults achieve of 16% or more at 72 weeks with Tirzepatide and blood pressure reduction:

While the weight loss benefits of drugs like Wegovy and Ozempic have appealed to many, they are not without risks, especially for pregnant women and those trying to conceive

With expert guidance to help you navigate the plateau on your weight loss journey

If hypersensitivity reactions occur, discontinue use of Ozempic or Rybelsus tablets, treat promptly per standard of care, and monitor until signs and symptoms resolve

Another client shared that after struggling with weight for years, Tirzepatide finally helped him break through a plateau

individual results vary These are averages from controlled clinical trials